Drug intelligence / Profile preview

Immuno RS

Development stage: Unknown
Lead developer: Laboratoires Audevard
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Immuno RS is a multi-ingredient nutritional supplement developed by Laboratoires Audevard specifically for equine immunity support. It is formulated to stimulate both innate and acquired immune mechanisms in horses during high-risk periods such as winter, intensive training, or travel. The product contains a combination of botanical extracts (Echinacea), fermentation-derived beta-glucans (Glucafeed®), probiotics (Saccharomyces cerevisiae), and essential vitamins (A, C, E) and minerals (zinc, selenium). It acts as an antioxidant and immune stimulant to support foals, senior horses, and those in convalescence. As a complementary feed supplement, it is administered orally as a powder and is designed to provide comprehensive support for the equine immune system.

Brand names: Immuno RS

Targets

CLEC7A (Dectin-1)

Beyond the preview

Go deeper on Immuno RS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immuno RS.

Explore the full profile